抗うつ薬 セルトラリン の 用途 を 変え て ください.その 抗がん 作用 の 体系 的 な 範囲 の 検討
Ciara B Blum1, McCarlie-Jayne Dohrmann1, Lucia McCarthy1
1School of Medicine and Dentistry, Griffith University, Southport, Queensland, Australia.
Pharmacology research & perspectives
|August 28, 2025
まとめ
抗うつ剤のSSRIであるセルトラリンは,アポトーシスを誘発し,がん細胞の代謝を妨害することで,抗がん作用を示す. 癌治療のための再利用は,臨床前データと好ましい安全性プロファイルによって支持されており,さらなる臨床試験を正当化しています.
科学分野:
- 腫瘍学
- 薬理学について
- 薬物の再利用
背景:
- 薬物の再利用は 新しいがん治療法を見つけるための 実行可能な戦略です
- 選択的セロトニン再吸収阻害剤 (SSRI) であるセルトラリンは,腫瘍の生存と抵抗経路に影響を与えることで,抗がん性を示す.
研究 の 目的:
- サートラリンの抗癌メカニズム,有効性,およびトランスレーションの可能性に関する証拠を体系的に検討する.
- 重要ながん関連の経路を調節するセルトラリンの役割を評価する.
主な方法:
- PRISMA-ScRのガイドラインに従って,主要なデータベース (PubMed,EMBASE,Scopus,Web of Science) で体系的な文献検索が行われました.
- 癌の種類,メカニズム,アウトカムに関するデータ抽出を含む,in vitro,in vivo,および臨床試験を含む研究.
主要な成果:
- セルトラリンはアポトーシスを誘発し,オートファギーと展開タンパク質応答を阻害し,セリン/グリシン代謝 (SHMT) を阻害する.
- 腫瘍的シグナル伝達 (mTOR,TCTP) を抑制し,臨床前モデル (乳房,肺,膠芽細胞腫,肝臓) で腫瘍の成長を抑制することが示された.
- 抵抗を克服し,免疫応答を調節することによって,セルトラリンは化学療法,放射線療法,および標的治療の有効性を高めます.
結論:
- セルトラリンは多標的抗癌メカニズムを示し,その再利用の可能性を支える好ましい安全性プロファイルを持っています.
- 主に臨床前の証拠は,腫瘍学における治療のニッチを確立するために,さらなる翻訳研究とバイオマーカー主導の臨床試験を必要とします.
関連する概念動画
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:34Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K